Publicacions en col·laboració amb investigadors/es de Hospital Universitario Príncipe de Asturias (30)

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor

    Egyptian Heart Journal, Vol. 74, Núm. 1

2021

  1. Serum hepatocyte growth factor as diagnostic tool in patients with acute chest pain

    Revista Colombiana de Cardiologia, Vol. 28, Núm. 6, pp. 564-572

2018

  1. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

2017

  1. Presión positiva al final de la espiración guiada por la complianza versus FiO2 aplicada en pacientes con distrés respiratorio agudo moderado o severo según la definición de Berlín

    Medicina Intensiva, Vol. 41, Núm. 5, pp. 277-284

2016

  1. Functional Status and Quality of Life in Elderly Intensive Care Unit Survivors

    Journal of the American Geriatrics Society, Vol. 64, Núm. 3, pp. 536-542

  2. Mortalidad y estado funcional al año de pacientes ancianos con ingreso prolongado en una unidad de cuidados intensivos

    Medicina Intensiva, Vol. 40, Núm. 5, pp. 289-297

  3. New Atlanta Classification of acute pancreatitis in intensive care unit: Complications and prognosis

    European Journal of Internal Medicine, Vol. 30, pp. 82-87

2014

  1. Aplicación individualizada de la presión positiva al final de la espiración en pacientes con síndrome de distrés respiratorio agudo

    Medicina Intensiva, Vol. 38, Núm. 8, pp. 498-501

  2. Protocolo diagnóstico y terapéutico de las neumonías nosocomiales

    Medicine (Spain), Vol. 11, Núm. 52, pp. 3081-3085

  3. Role of Circulating Lymphocytes in Patients with Sepsis

    BioMed Research International, Vol. 2014

2013

  1. Characteristics and outcomes of elderly patients refused to ICU

    The Scientific World Journal, Vol. 2013

  2. Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome

    European Journal of Internal Medicine, Vol. 24, Núm. 2, pp. 132-138

  3. Early alterations of B cells in patients with septic shock

    Critical Care, Vol. 17, Núm. 3

  4. Individualized PEEP setting in subjects with ARDS: A randomized controlled pilot study

    Respiratory Care, Vol. 58, Núm. 9, pp. 1416-1423

  5. Papel de las quimioquinas solubles circulantes en el shock séptico

    Medicina Intensiva, Vol. 37, Núm. 8, pp. 510-518

2012

  1. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels

    European Journal of Internal Medicine, Vol. 23, Núm. 4, pp. 358-362

  2. The predictive role of early activation of natural killer cells in septic shock

    Critical Care

2011

  1. Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction

    Acta Cardiologica, Vol. 66, Núm. 3, pp. 315-321

  2. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support

    Archives of Internal Medicine, Vol. 171, Núm. 21, pp. 1939-1946